Background: The characteristics of writer's cramp (WC) may vary according to native languages and scripts. We report the clinical profile of a large cohort of patients with WC from India. Methods: A chart review of 125 patients (F:M = 16:109) with WC seen over 10 years at the National Institute of Mental Health and Neurosciences (NIMHANS), India. Results: The mean age of patients was 36.8 ± 14.3, the mean age at onset (AAO) of symptoms was 31.5 ± 2.7 and the mean duration of difficulty in writing was 5.3 ± 6.3. The most common presenting complaint while writing was pain in the forearm (56%), followed by tremulousness of hand (28.8%) and abnormal posturing of hand (15.2%). Along with writing difficulty, 5.6% had difficulty in typing. The mean AAO of writing difficulty was significantly earlier in women than in men (22.8 ± 3.5 vs. 32.8 ± 4.2 years, p < 0.001). While writing, excessive extension (41.6%) of wrist was the most common abnormality, followed by excessive flexion (37.6%) and extension (19.2%) of index finger. Conclusions: Women with WC have a significantly earlier age of onset than men. Excessive extension of wrist with flexion of thumb and index finger were the most common abnormalities noted in WC.

Keywords:
Writerߣs cramp, Focal dystonia, Tremor
1.
Altschuler EL: Ramazzini and writer's cramp. Lancet 2005;365:938.
2.
Sheehy MP, Marsden CD: Writers' cramp - a focal dystonia. Brain 1982;105:461-480.
3.
Deuschl G, Heinen F, Guschlbauer B, Schneider S, Glocker FX, Lücking CH: Hand tremor in patients with spasmodic torticollis. Mov Disord 1997;12:547-552.
4.
Byl NN, Archer ES, McKenzie A: Focal hand dystonia: effectiveness of a home program of fitness and learning-based sensorimotor and memory training. J Hand Ther 2009;22:183-197; quiz 198.
5.
Das CP, Prabhakar S, Truong D: Clinical profile of various sub-types of writer's cramp. Parkinsonism Relat Disord 2007;13:421-424.
6.
Jedynak PC, Tranchant C, de Beyl DZ: Prospective clinical study of writer's cramp. Mov Disord 2001;16:494-499.
7.
Lungu C, Karp BI, Alter K, Zolbrod R, Hallett M: Long-term follow-up of botulinum toxin therapy for focal hand dystonia: outcome at 10 years or more. Mov Disord 2011;26:750-753.
8.
Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group: A prevalence study of primary dystonia in eight European countries. J Neurol 2000;247:787-792.
9.
Soland VL, Bhatia KP, Marsden CD: Sex prevalence of focal dystonias. J Neurol Neurosurg Psychiatry 1996;60:204-205.
10.
Djebbari R, du Montcel ST, Sangla S, Vidal JS, Gallouedec G, Vidailhet M: Factors predicting improvement in motor disability in writer's cramp treated with botulinum toxin. J Neurol Neurosurg Psychiatry 2004;75:1688-1691.
11.
Das SK, Banerjee TK, Biswas A, Roy T, Raut DK, Chaudhuri A, et al: Community survey of primary dystonia in the city of Kolkata, India. Mov Disord 2007;22:2031-2036.
12.
Sex-related influences on the frequency and age of onset of primary dystonia. Epidemiologic Study of Dystonia in Europe (ESDE) Collaborative Group. Neurology 1999;53:1871-1873.
13.
Duane DD: Spasmodic torticollis: clinical and biologic features and their implications for focal dystonia. Adv Neurol 1988;50:473-492.
14.
Cohen LG, Hallett M, Sudarsky L: A single family with writer's cramp, essential tremor, and primary writing tremor. Mov Disord 1987;2:109-116.
15.
Rosenbaum F, Jankovic J: Focal task-specific tremor and dystonia: categorization of occupational movement disorders. Neurology 1988;38:522-527.
16.
Roze E, Soumaré A, Pironneau I, Sangla S, de Cock VC, Teixeira A, Elbaz A: Case-control study of writer's cramp. Brain 2009;132:756-764.
17.
Delmaire C, Vidailhet M, Elbaz A, Bourdain F, Bleton JP, Sangla S, et al: Structural abnormalities in the cerebellum and sensorimotor circuit in writer's cramp. Neurology 2007;69:376-380.
18.
Garraux G, Bauer A, Hanakawa T, Wu T, Kansaku K, Hallett M: Changes in brain anatomy in focal hand dystonia. Ann Neurol 2004;55:736-739.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.